Sunday, August 23, 2020

Vaccine Nationalism: The Ethical Conundrum in the age of Global Pandemic

This article is by

Share this article

Article Contributor(s)

Hardi Talwani

Article Title

Vaccine Nationalism: The Ethical Conundrum in the age of Global Pandemic

Publisher

Global Views 360

Publication Date

August 23, 2020

URL

COVID-19 Vaccine Race

COVID-19 Vaccine Race | Source: Alfredo Martirena via Cartoon Movement

O People! Make way for the latest horrendous development of the infamous year 2020. We have straight out of the oven, the freshest item on the menu of ethical conundrums “Vaccine Nationalism”.

It seems like the cure is as dangerous as people dying of the COVID-19. Currently, according to the WHO, six vaccines have reached phase 3 trials, while 25 vaccines are in the clinical evaluation phase and 139 in pre-clinical evaluation.

COVID-19 Vaccine Nationalism | Marian Kamensky via Cartoon Movement

When the pandemic hit different parts of the world, the first response of the humans was to attack supermarkets and hoard loads of groceries (yes, toilet papers too). Vaccine Nationalism is just analogous to hoarding toilet papers, except, it’s just a phenomenon that occurs when rich countries pay for vaccines in advance and hoard them. Don’t worry politicians are not doing what they did not promise: remember ‘America first?’ and ‘India first?’

A global initiative by WHO – ACT (Access to COVID-19 Tools) Accelerator- aims at a cumulative process of R&D, manufacturing, regulatory, purchasing and procurement needed to fight against COVID-19. Unfortunately, the USA, Russia, India, and China did not receive the initiative with much-needed enthusiasm. The WHO also came up with another program called COVAX facility, that aims to provide 2 billion doses of vaccine by the end of the next year for middle and low-income countries.

Source: Brandon Reynolds via BusinessDay

The US compared its operation ‘Warp speed’ to the oxygen masks dropping during the flights. Russia tried to jump ahead, attempting to create a Sputnik moment. Russian President announced Russia curated the first COVID-19 vaccine called Sputnik V. The vaccines are still under trials and need much more necessary testing to work. Safe to say, Russia’s plan backfired earning them international scorn.

Vaccine nationalism will lead to global dysfunction. Rich countries will benefit as they can bid for the vaccine at high prices. Such high prices will lead to a disaster for the low-income countries, adding to their already deficient health care. These desperate countries will have no choice but to buy vaccines driving their economies in an even worse condition. Additionally, a single country having a vaccine will not help the problem in any way at all. Some nations have already gambled their chances of acquiring vaccines by speaking against other countries.

The unethical practice of Vaccine Nationalism is not at all unexpected. A bid against humanity is not entirely new. Similar responses were noted in 2009 when the world H1N1 flu crisis hit. Australia came up with a vaccine and sold 6,00,00 doses to the USA, blocking the exports to other countries. Once the effect of flu started diminishing, rich countries donated the vaccines to low-income nations. A similar situation happened in 2014 when the EBOLA crisis hit.

Politics aside, scientists are staying out of it and trying to work together for greater good. Instead of publishing research papers they are working collaboratively throughout the world. We must not forget that finding a cure or a significant role can earn a lot of scientists, assets, reputation, and promotions. Some lure away and are suspicious of sharing their work as well.

Rabindranath Tagore’s Portrait | Source: Wikimedia

When the search for a vaccine against such deadly disease mutates into a naked display of Vaccine Nationalism, Indian Nobel Laureate Rabindranath Tagore’s view on nationalism becomes an antidote. He believed in an idea of nationalism without borders. Tagore once described in a letter to his friend AM Bose that “the value of patriotism can never be greater than the value of humanity.”

It is a human tendency to compete and nature supports the fittest. How fit is it though to use strong nations’ ability to bully other unequipped nations? How generous is it to help others when they don’t even need help anymore? How ethical and moral is to block vaccine procurement for other countries for monetary and economic benefits?

These are some of the questions lost in the drumbeats of Vaccine Nationalism which is echoing across the continents. It's high time that concerned citizens should demand answers from their respective government to come clean on the real motive behind the call for developing a vaccine for global pandemic in a silo, when it actually needs global cooperation.

Support us to bring the world closer

To keep our content accessible we don't charge anything from our readers and rely on donations to continue working. Your support is critical in keeping Global Views 360 independent and helps us to present a well-rounded world view on different international issues for you. Every contribution, however big or small, is valuable for us to keep on delivering in future as well.

Support Us

Share this article

Read More

February 4, 2021 5:14 PM

Asian countries & the race for COVID-19 Vaccine

Our relationship with the new strain of coronavirus is almost 8 months strong now. Countries like the US, Russia, UK, China, India, and many more have already set their brainy scientists in the task of developing a vaccine, turning it into a race which desperately needs a winner, since no one wants this deadly relationship to endure. Several attempts have proved to be successful, especially in countries like Russia, USA, India, and China.

China was the first to start scouring for a vaccine the day WHO declared that the new strain of SARS-CoV, originating in Wuhan-China, has resulted in a pandemic. It is a fierce competitor, especially to the US, as almost 8 of the 24 promising vaccines approved for clinical trials are from China. It used the technology of ‘inactivated vaccine’ which basically means killing the actual virus and using that to create a vaccine. This method is quite useful in treating measles and influenza, thus, increasing the chances of success in the case of COVID-19 as well.

“It’s a tried and true strategy”, Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia, said  about the inactivated vaccine. One potential vaccine from China-based Sinopharm is already in the phase 3 of trials whereas Sinovac will enter the third phase this month. Moreover, China has permitted Sinovac and Sinopharm to dilute phase 1 and 2 of vaccine trials on humans to hasten the process.

The head of the Chinese Center for Disease Control and Prevention, Gao Fu, had also been injected with a potential vaccine on July 28, 2020. “I’m going to reveal something undercover: I am injected with one of the vaccines'' Gao Fu said in a webinar hosted by Alibaba Health, an arm of the Chinese e-commerce giant, and Cell Press, an American publisher of scientific journals. However, he did not reveal any more details about how and when exactly he administered himself with the vaccine and ‘hopes’ that the vaccine works.

Vladimir Putin, President of Russia | Source: Wikimedia

Elsewhere in Russia, on August 11, 2020, President Vladimir Putin proudly announced that Russia was the first country to grant regulatory approval to their vaccine after carrying out human trials for less than 2 months by the Gamalei Institute in Moscow. Regulatory approval permits vaccination of the masses. Although it has not undergone phase 3 of trials, Russia expects to initiate mass production of the vaccine by the end of this year. Kirill Dmitriev, head of Russia's sovereign wealth fund states that the vaccine will be called ‘Sputnik V’, named after Sputnik 1, the first satellite launched by Soveit Union which was a euphoric moment for Russia. More recently, China and Russia have joined hands in proceeding with the clinical trials of their vaccines.

These two instances seem to bring a new hope for the future, yet raise alarms and invite scepticism from the experts in the field of public health. One major concern is that without prolonged trials, vaccines should not be authorized for public use. Anthony Fauci, an infectious disease expert based in the US said “I do hope the Chinese and the Russians are actually testing the vaccines before they are administering the vaccine to anyone. Because claims of having a vaccine ready to distribute before you do testing is problematic at the very least”. Hence, some people are still in doubt regarding the safety of the product. Putin, however, rubbished such concerns and said "I know that it works quite effectively, forms strong immunity, and I repeat, it has passed all the needed checks".

An Indian biotechnological company, Bharat Biotech developed ‘Covaxin’ in collaboration with Indian Council for Medical Research (ICMR), using the mechanism of inactivated vaccine. It was successful in getting approval for human trials which were scheduled to begin in July, 2020. Initial reports stated that it would be ready for mass use by August 15, 2020, which also marked the 73rd Independence Day of India. However, Bharat biotech was clear in letting the public know that phase 1 of the trials are still on-going. ICMR cleared the confusion by stating that it would prepare the results of the phase 1 trials by August 15, 2020, not the actual vaccine for use. Phase 2 of the trials are awaited in September, 2020.

So far, the results of phase 1 trials have been positive as no serious side-effects are observed in the vaccine candidates. “The vaccine has been safe. No adverse effect has been reported. Even the point of injection pain, which is normal in vaccines, has been very mild” said Dr Kushwaha of Prakhar Hospital.

Meanwhile, the South Korean government stated on August 21, 2020, that it will secure adequate vaccine supply to its citizens by cooperating with international bodies and promoting local drug development. Three South Korean companies have started the process of making a vaccine and all are in the clinical trial phase. Bill Gates asserts that the South Korean pharmaceutical company, SK Bioscience, will have around 200 million vaccine doses ready by June 2021.

Japan is jointly collaborating with the UK, France and other European countries to establish a $20 billion fund to buy coronavirus vaccines, with Japan pledging a contribution of $800 million. It’s vaccine program aims to focus on giving primary attention to its medical workers and the elderly people of the country when the first doses of the vaccine are made. The state-funded vaccination program is believed to be officially adopted by Japan in September this year with negotiations with the UK and US based drug makers already in place.

With the race to bring COVID-19 vaccine seemingly coming to a close and it will hopefully be ready by the end of 2020 or early 2021. Till then, the entire world is watching this race with bated breath.

Read More